News & Events

April 2015

CDI__small_logo Share: facebook16x16px_green  twitter16x16px_green
masthead_enewsletter_CDINotebook

April 2015

promo_sf_reduced

Welcome to our monthly enewsletter, CDI Notebook, focused on keeping you abreast of the latest innovations using CDI’s iCell® and MyCell® products.

In this issue:
Trending
Webinars
Applications
Press
Conference News
Presentations/Posters

enewsletter_hr-big

Trending

trending

Now Available! iCell Cardiomyocytes2. Experience how these biologically relevant cardiomyocytes can exponentially increase productivity through reduced experimental handling and laboratory time.

Details>>

enewsletter_hr-big

Webinars

Using Human Cardiomyocytes in Phenotypic Screens and Target Verification (Originally aired Mar 31). Hear about the implementation of phenotypic screens for cardioprotective molecules, potential therapeutic avenues for cardiac hypertrophy, and methods for validating key targets in dilated cardiomyopathy.

Recording>>

Diabetic Cardiomyopathy Modeling & Screening with iPSC Cardiomyocytes (Originally aired Apr 7). Learn about the development of environmentally and genetically driven in vitro models for diabetic cardiomyopathy and their use in phenotypic screens to identify potential drug discovery pathways.

Recording>>

enewsletter_hr-big

Applications

application_xCELLigence

Measuring Cardiac Activity: Impedance Detection with xCELLigence RTCA Cardio System. Evaluate compound efficacy, potency, and toxicity utilizing iCell Cardiomyocytes2 and the xCELLigence RTCA Cardio System.

Protocol>>

application_Maestro

Measuring Cardiac Electrical Activity: Field Potential Detection on the Maestro Multielectrode Array. Implement iCell Cardiomyocytes2 with the Maestro multielectrode array to assess compound effects and the electrophysiological properties of the cardiomyocytes.

Protocol>>

application_Hypoxia

Modeling Cardiac Ischemia: Hypoxia Induction for Cardioprotection Screening. Induce hypoxia in iCell Cardiomyocytes, analyze the cellular responses, and test for cardioprotective compounds.

Protocol>>

enewsletter_hr-big

Press

Interpreting Toxicity’s Portents (GEN). Read about innovative technologies, including human iPSC-derived cells and high content analysis, that researchers are implementing to predict the adverse effect of compounds earlier in the drug discovery process.

Article>>

enewsletter_hr-big

Conference News

Stop by the CDI exhibit if you’re attending one of these upcoming meetings:

  • BNA 2015 Festival of Neuronscience (Apr 12 – 15 | Edinburgh, Scotland)
  • International Meeting of the Stem Cell Network NRW (Apr 21 – 22 | Bonn, Germany)
  • Wisconsin Stem Cell Symposium (Apr 22 | Madison, WI)
  • European Pharma Summit: 2nd Tissue Models & Drug Screening Conference (May 5 – 6 | Berlin, Germany)

2015 Events>>

enewsletter_hr-big

Presentations/Posters

Access these posters and presentations, presented at recent meetings, online:

    • Characterization of an Isogenic Disease Model of Alzheimer’s Disease from Human iPS Cell-derived Neurons (AD/PD 2015)

Poster>>

presentation

    • Development and Characterization of Scalable Human Induced Pluripotent Stem Cell-derived Midbrain Dopaminergic Neurons for Drug Discovery and Disease Modeling (AD/PD 2015)

Poster>>

    • Integrating Target-based and Phenotypic Screening Strategies with Human Cardiomyocytes: Using iPSC Technology and Clinical Populations to Identify New Approaches for Treating Cardiac Hypertrophy (SLAS2015)

Presentation (Video)>>

    • Using Patient Specific iPSC-cardiomyocytes for Disease Modeling (SLAS2015)

Presentation (Video)>>

enewsletter_hr-big
© 2015 Cellular Dynamics International, Inc.
525 Science Drive, Madison, WI 53711
+1 (608) 310-5100 or toll-free (877) 310-6688
www.cellulardynamics.com
Follow us: facebook16x16px_green linkedin16x16px_green twitter16x16px_green youtube16x16px_green